Basel Medical Group Ltd Ordinary Shares
BMGLBasel Medical Group Ltd is a healthcare company focused on the development, manufacture, and distribution of advanced medical devices and solutions. The company specializes in areas such as minimally invasive procedures, diagnostic imaging, and healthcare technology, aiming to improve patient outcomes and streamline medical practices.
Company News
Basel Medical Group Ltd (BMGL) announced on July 10, 2026 that it has regained compliance with Nasdaq's minimum bid price rule of $1.00 per share. The company had been notified of non-compliance in January 2026 but successfully maintained the required minimum closing bid price for 10 consecutive business days from June 23-July 7, 2026.
Basel Medical Group Ltd (Nasdaq: BMGL), a Singapore-based medical clinic operator, announced a 1-for-12 reverse stock split effective June 22, 2026, to comply with Nasdaq's minimum bid price requirement of $1 per share. The consolidation will reduce outstanding shares from approximately 18.8 million to 1.6 million shares.
Basel Medical Group, a Singapore-based healthcare provider, has completed the acquisition of Bethesda Medical, a leading Singapore-based healthcare provider. The acquisition aims to strengthen Basel Medical Group's presence in Singapore and the broader Southeast Asian healthcare market.
Basel Medical Group, a Singapore-based healthcare provider, has signed an agreement to acquire Bethesda Medical, a leading diagnostic imaging and outpatient care provider in Singapore. The acquisition aims to strengthen Basel Medical's presence in the Singapore and Southeast Asian healthcare market.
